…
iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and FreeTalk; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, bekids Library, and the Gogo series; Reading Stars; and Aha World and Aha Makeover. It also provides offline products, such as iHuman AI Pal, a plush AI companion; and the iHuman AI Bilingual Early Learning Tablet, an AI-powered smart learning tablet that delivers a bilingual Chinese-English content library for children. In addition, the company offers intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. Further, it engages in the operation of online applications; provision of management and technical consulting; and research and development activities. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Ihuman Inc (IH.US) is limited and available sources do not provide a clear, independently verifiable description of its core operations. Investors should consult the company's SEC filings and investor relations for details; without those disclosures, long-term growth drivers cannot be reliably identified, although investors may find potential if the firm demonstrates a scalable market and a defensible model.
Primary risks include limited transparency and disclosure, potential early-stage or restructuring status, liquidity and financing uncertainty, and governance or operational risk that could impair execution.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 101.79M | 110.60M | 202.57M | 132.77M | -37.20M |
| Net income | 95.40M | 98.59M | 180.91M | 109.82M | -37.05M |
| Selling general administrative | 91.44M | 99.25M | 104.33M | 109.19M | 97.44M |
| Selling and marketing expenses | 180.97M | 221.23M | 199.50M | 156.92M | 202.09M |
| Gross profit | 547.61M | 640.15M | 721.27M | 691.17M | 660.62M |
| Reconciled depreciation | 7.75M | 13.66M | 11.69M | 10.83M | 6.42M |
| Ebit | 101.79M | 110.60M | 202.57M | 100.75M | -60.67M |
| Ebitda | 109.54M | 124.26M | 214.26M | 111.58M | -54.25M |
| Depreciation and amortization | 7.75M | 13.66M | 11.69M | 10.83M | 6.42M |
| Operating income | 66.76M | 71.91M | 159.89M | 111.58M | -54.25M |
| Other operating expenses | 740.26M | 850.29M | 858.25M | 873.93M | 998.97M |
| Interest expense | - | - | - | 21.19M | 23.47M |
| Tax provision | 6.39M | 12.01M | 33.10M | 22.95M | -0.14M |
| Interest income | - | - | 28.54M | - | - |
| Net interest income | - | - | 28.54M | - | - |
| Income tax expense | 6.39M | 12.01M | 21.67M | 22.95M | -0.14M |
| Total revenue | 807.02M | 922.20M | 1018.14M | 985.52M | 944.72M |
| Total operating expenses | 480.85M | 568.24M | 561.38M | 579.59M | 714.87M |
| Cost of revenue | 259.41M | 282.05M | 296.87M | 294.34M | 284.10M |
| Total other income expense net | 35.03M | 38.69M | 42.69M | 21.19M | 17.05M |
| Net income from continuing ops | 95.40M | 98.59M | 183.07M | 109.82M | -37.05M |
| Net income applicable to common shares | 95.40M | 98.59M | 180.91M | 109.82M | -37.05M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1369.23M | 1419.64M | 1450.49M | 1333.40M | 1100.88M |
| Intangible assets | 17.65M | 16.43M | 23.25M | 24.87M | 27.29M |
| Other current assets | 74.53M | 89.51M | 89.51M | 102.77M | 72.85M |
| Total liab | 373.42M | 458.80M | 492.69M | 563.95M | 492.51M |
| Total stockholder equity | 995.80M | 960.85M | 957.80M | 769.45M | 608.37M |
| Other current liab | 116.89M | 114.22M | 119.37M | 151.66M | 124.75M |
| Common stock | 0.19M | 0.18M | 0.18M | 0.18M | 0.18M |
| Capital stock | 0.19M | 0.18M | 0.18M | 0.18M | 0.18M |
| Retained earnings | 53.26M | -42.10M | -140.46M | -321.17M | -423.02M |
| Other assets | 11.86M | 22.70M | 8.66M | 6.42M | 7.83M |
| Cash | 1151.85M | 1123.29M | 1213.77M | 1050.00M | 855.36M |
| Cash and equivalents | 1151.12M | 1123.29M | 1213.77M | 1050.00M | 855.36M |
| Total current liabilities | 364.21M | 447.54M | 490.76M | 561.05M | 482.93M |
| Current deferred revenue | 220.05M | 283.25M | 318.59M | 379.06M | 302.98M |
| Net debt | -1140.47M | -1108.38M | -1209.91M | -1040.98M | -821.12M |
| Short term debt | 2.17M | 3.66M | 1.93M | 6.12M | 24.67M |
| Short long term debt total | 11.38M | 14.91M | 3.86M | 9.02M | 34.25M |
| Other stockholder equity | 917.74M | 970.36M | 1071.96M | 1071.98M | 1065.89M |
| Property plant equipment | 14.15M | 18.36M | 9.82M | 21.99M | 50.52M |
| Total current assets | 1299.20M | 1335.82M | 1382.44M | 1253.79M | 1015.24M |
| Long term investments | 26.33M | 26.33M | 26.33M | 26.33M | - |
| Net tangible assets | - | - | - | - | 581.08M |
| Short term investments | 0.00M | 45.46M | 0.00M | - | - |
| Net receivables | 51.42M | 54.08M | 62.64M | 81.90M | 58.98M |
| Inventory | 21.40M | 23.48M | 16.52M | 19.13M | 28.05M |
| Accounts payable | 25.10M | 30.23M | 22.14M | 24.21M | 30.54M |
| Accumulated other comprehensive income | 24.61M | 32.40M | 26.12M | 18.46M | -34.68M |
| Treasury stock | - | - | - | - | -0.16M |
| Non currrent assets other | 11.87M | 22.70M | 8.66M | 6.42M | 7.83M |
| Non current assets total | 70.02M | 83.82M | 68.06M | 79.61M | 85.64M |
| Capital lease obligations | 11.37M | 14.91M | 3.86M | 9.02M | 34.25M |
| Long term debt total | - | 0.00M | 0.00M | - | 0.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 45.46M | -52.76M | -6.51M | -32.84M | -31.95M |
| Change to liabilities | - | - | - | 69.75M | 43.35M |
| Total cashflows from investing activities | 39.45M | -52.76M | -6.51M | -32.84M | -31.95M |
| Total cash from financing activities | -54.56M | -102.28M | -9.45M | -6.96M | 0.41M |
| Change to operating activities | - | - | - | -21.99M | -22.09M |
| Net income | 95.40M | 98.59M | 180.91M | 109.82M | -37.05M |
| Change in cash | 75.75M | -90.47M | 163.77M | 194.64M | -6.32M |
| Begin period cash flow | 1076.10M | 1213.77M | 1050.00M | 855.36M | 861.68M |
| End period cash flow | 1151.85M | 1123.29M | 1213.77M | 1050.00M | 855.36M |
| Total cash from operating activities | 49.92M | 58.55M | 172.12M | 188.47M | 38.21M |
| Issuance of capital stock | - | - | - | 0.00M | 0.00M |
| Depreciation | 7.75M | 13.66M | 11.69M | 10.83M | 6.42M |
| Other cashflows from investing activities | -0.00M | -45.31M | 0.00M | - | 0.33M |
| Dividends paid | 38.02M | 35.27M | 0.00M | 0.00M | 0.00M |
| Change to inventory | 0.44M | -7.24M | 3.03M | 6.72M | -12.62M |
| Change to account receivables | 2.74M | 8.98M | 18.77M | -28.51M | 21.61M |
| Sale purchase of stock | -16.72M | -9.63M | -9.54M | -6.96M | -0.16M |
| Other cashflows from financing activities | -0.00M | -57.38M | 0.09M | 0.00M | 0.57M |
| Change to netincome | - | - | - | 41.84M | 38.60M |
| Capital expenditures | 4.77M | 7.45M | 6.51M | 6.59M | 32.28M |
| Change in working capital | -55.93M | -58.54M | -40.35M | 25.97M | 30.25M |
| Stock based compensation | 0.72M | 2.82M | 9.44M | 13.04M | 15.18M |
| Other non cash items | 1.98M | 2.01M | 10.44M | 28.80M | 21.75M |
| Free cash flow | 45.15M | 51.10M | 165.61M | 181.88M | 5.93M |
Sector: Consumer Defensive Industry: Education & Training Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IH Ihuman Inc |
-0.02 1.72% |
1.14 | 5.80 | 58.82 | 0.08 | 0.42 | 0.05 | 0.75 |
| EDU New Oriental Education & Technology |
1.03 1.91% |
54.99 | 18.94 | 12.42 | 1.60 | 2.27 | 0.84 | 7.37 |
| NWOEF New Oriental Education & Technology Group Inc. |
- -% |
4.52 | 15.07 | 9.88 | 1.27 | 1.80 | 0.87 | 7.67 |
| TAL TAL Education Group |
-0.03 0.29% |
10.16 | 7.34 | 9.21 | 2.04 | 1.58 | 1.25 | 10.01 |
| LAUR Laureate Education Inc |
0.30 0.90% |
33.59 | 16.23 | 15.31 | 2.70 | 4.44 | 3.08 | 9.75 |
iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and FreeTalk; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, bekids Library, and the Gogo series; Reading Stars; and Aha World and Aha Makeover. It also provides offline products, such as iHuman AI Pal, a plush AI companion; and the iHuman AI Bilingual Early Learning Tablet, an AI-powered smart learning tablet that delivers a bilingual Chinese-English content library for children. In addition, the company offers intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. Further, it engages in the operation of online applications; provision of management and technical consulting; and research and development activities. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.
| Name | Title | Year Born |
|---|---|---|
| Mr. Peng Dai | CEO & Director | 1980 |
| Ms. Weiwei Wang | CFO & Director | 1978 |
| Mr. Wenbin Lu | Chief Technology Officer | 1984 |
| Mr. Yufeng Chi | Founder & Chairman | 1971 |
| Mr. Teng Li | Co-Chief Executive Officer | NA |
| Ms. Congyu Lin | Chief Strategy Officer (CSO) | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.